NEKTAR THERAPEUTICS - Daily - Technical analysis published on 07/16/2019 (GMT)
- 333
- 0
- Who voted?
I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : TARGET REACHED
Summary of the analysis
Trends
Court terme:
Strongly bearish
De fond:
Bearish
Technical indicators
22%
56%
22%
My opinion
Bearish under 36.29 USD
My targets
30.71 USD (-7.19%)
22.92 USD (-30.73%)
My analysis
NEKTAR THERAPEUTICS is part of a very strong bearish trend. Traders may consider trading only short positions (for sale) as long as the price remains well below 36.29 USD. The next support located at 30.71 USD is the next bearish objective to target. A bearish break of this support would revive the bearish momentum. The bearish movement could then continue towards the next support located at 22.92 USD. Below this support, sellers could then target 3.52 USD.
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Vincent Launay. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
The NEKTAR THERAPEUTICS price is 33.09 USD. The price registered a decrease of -0.36% on the session and was between 32.85 USD and 33.50 USD. This implies that the price is at +0.73% from its lowest and at -1.22% from its highest.32.85
33.50
33.09
The Central Gaps scanner detects a bullish opening. A small advantage for buyers in the very short term.
Bullish opening
Type : Bullish
Timeframe : Openning
A study of price movements over other periods shows the following variations:
Near a new LOW record (1 month)
Type : Bearish
Timeframe : Weekly
Technical
A technical analysis in Daily of this NEKTAR THERAPEUTICS chart shows a bearish trend. 75% of the signals given by moving averages are bearish. This bearish trend is supported by the strong bearish signals given by short-term moving averages. The Central Indicators scanner detects a bearish signal on moving averages that could impact this trend:
Bearish price crossover with Moving Average 50
Type : Bearish
Timeframe : Daily
In fact, Central Analyzer took into account 18 technical indicators and the result was as follows: 4 are bullish, 4 are neutral and 10 are bearish. But beware of excesses. The Central Indicators scanner currently detects this:
CCI indicator is oversold : under -100
Type : Neutral
Timeframe : Daily
Williams %R indicator is oversold : under -80
Type : Neutral
Timeframe : Daily
Ichimoku : price is under the cloud
Type : Bearish
Timeframe : Daily
Price is back under the pivot point
Type : Bearish
Timeframe : Daily
Price is back under the pivot point
Type : Bearish
Timeframe : Weekly
The Central Patterns scanner, which studies chart patterns, resistances and supports, has identified this signal:
Near support of channel
Type : Bullish
Timeframe : Daily
No result was found by the Central Candlesticks scanner on Japanese candlesticks.
ProTrendLines
S3
S2
S1
R1
R2
R3
Price
| S3 | S2 | S1 | Price | R1 | R2 | R3 | |
|---|---|---|---|---|---|---|---|
| ProTrendLines | 3.52 | 22.92 | 30.71 | 33.09 | 36.29 | 40.58 | 46.32 |
| Change (%) | -89.36% | -30.73% | -7.19% | - | +9.67% | +22.64% | +39.98% |
| Change | -29.57 | -10.17 | -2.38 | - | +3.20 | +7.49 | +13.23 |
| Level | Minor | Major | Major | - | Major | Minor | Major |
Pivot points can also be used to set your price objectives. Here is the price situation in relation to pivot points:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 31.67 | 32.21 | 32.71 | 33.25 | 33.75 | 34.29 | 34.79 |
| Camarilla | 32.92 | 33.02 | 33.12 | 33.21 | 33.31 | 33.40 | 33.50 |
| Woodie | 31.65 | 32.20 | 32.69 | 33.24 | 33.73 | 34.28 | 34.77 |
| Fibonacci | 32.21 | 32.61 | 32.85 | 33.25 | 33.65 | 33.89 | 34.29 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 30.32 | 31.63 | 32.68 | 33.99 | 35.04 | 36.35 | 37.40 |
| Camarilla | 33.07 | 33.29 | 33.50 | 33.72 | 33.94 | 34.15 | 34.37 |
| Woodie | 30.18 | 31.57 | 32.54 | 33.93 | 34.90 | 36.29 | 37.26 |
| Fibonacci | 31.63 | 32.54 | 33.09 | 33.99 | 34.90 | 35.45 | 36.35 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 28.62 | 30.43 | 33.00 | 34.81 | 37.38 | 39.19 | 41.76 |
| Camarilla | 34.38 | 34.78 | 35.18 | 35.58 | 35.98 | 36.38 | 36.79 |
| Woodie | 29.01 | 30.62 | 33.39 | 35.00 | 37.77 | 39.38 | 42.15 |
| Fibonacci | 30.43 | 32.10 | 33.13 | 34.81 | 36.48 | 37.51 | 39.19 |
Numerical data
The following is the status of technical indicators and moving averages registered at the time this technical analysis was created:
Technical indicators
Moving averages
| RSI (14): | 42.78 | |
| MACD (12,26,9): | -0.0500 | |
| Directional Movement: | -6.00 | |
| AROON (14): | -50.00 | |
| DEMA (21): | 34.31 | |
| Parabolic SAR (0,02-0,02-0,2): | 36.03 | |
| Elder Ray (13): | -0.99 | |
| Super Trend (3,10): | 32.44 | |
| Zig ZAG (10): | 33.07 | |
| VORTEX (21): | 0.9700 | |
| Stochastique (14,3,5): | 12.05 | |
| TEMA (21): | 34.00 | |
| Williams %R (14): | -94.82 | |
| Chande Momentum Oscillator (20): | -1.72 | |
| Repulse (5,40,3): | -2.9300 | |
| ROCnROLL: | 2 | |
| TRIX (15,9): | 0.1300 | |
| Courbe Coppock: | 3.80 |
| MA7: | 33.91 | |
| MA20: | 34.67 | |
| MA50: | 33.74 | |
| MA100: | 34.24 | |
| MAexp7: | 33.85 | |
| MAexp20: | 34.22 | |
| MAexp50: | 34.14 | |
| MAexp100: | 35.16 | |
| Price / MA7: | -2.42% | |
| Price / MA20: | -4.56% | |
| Price / MA50: | -1.93% | |
| Price / MA100: | -3.36% | |
| Price / MAexp7: | -2.25% | |
| Price / MAexp20: | -3.30% | |
| Price / MAexp50: | -3.08% | |
| Price / MAexp100: | -5.89% |
News
Don"t forget to follow the news on NEKTAR THERAPEUTICS. At the time of publication of this analysis, the latest news was as follows:
- First-in-Human Data Presented from Phase 1a Study of NKTR-358, a Novel T Regulatory Cell Stimulator, at Annual European Congress of Rheumatology
- Nektar Therapeutics to Host Webcast Conference Call with Immunology Expert for Analysts & Investors During 2019 European Congress of Rheumatology (EULAR 2019)
- Nektar Therapeutics Presents Biomarker and Clinical Data from PIVOT-02 Phase 2 Study of Bempegaldesleukin with Nivolumab at 2019 ASCO Annual Meeting
- Trovagene Announces Research Collaboration with Nektar Therapeutics to Evaluate Efficacy of the Combination of Onvansertib and ONZEALD™ in Models of Colorectal Cancer
- Nektar Therapeutics Announces Five Accepted Abstracts at 2019 American Society of Clinical Oncology's (ASCO) Annual Meeting
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis NEKTAR THERAPEUTICS - Daily